trustmebro.to/r/…

✓ checked

trust me, bro:

here is the receipt.

the claim

Ozempic causes bone loss

the verdict

CONTESTED

contested - the weight sits with the supporting side

Recorded sources

4 sources for · 2 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Ozempic causes bone loss?

Partly. Clinical and retrospective studies indicate that GLP-1 receptor agonists like Ozempic (semaglutide) are associated with reductions in bone mineral density driven primarily by weight loss, though some experimental and genetic studies suggest these effects may be modest or comparable to weight-loss-induced unloading rather than a direct toxic effect on bone.

Verdict: CONTESTED · 4 sources for, 2 against · Last checked 6 Aug 2026

The analysis

The retrieved literature contains conflicting evidence regarding the effects of GLP-1 receptor agonists (such as semaglutide and tirzepatide) on bone health. Several clinical and retrospective studies (e.g., Liu et al., and the 2026 retrospective study on semaglutide and tirzepatide) report significant decreases in bone mineral density associated with treatment and weight loss. Conversely, controlled animal comparisons (such as the mouse study showing semaglutide preservation compared to bariatric surgery) and Mendelian randomization analyses find no direct causal link between GLP-1 receptor expression and bone loss. Therefore, the evidence is CONTESTED.

The evidence we hold leans leans supported

How this was weighed

official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x

Skeletal Effect of Semaglutide and Tirzepatide in Patients w · peer-reviewed · supports · weight 1.05 · 2026
Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes · peer-reviewed · supports · weight 1.05 · 2025
MON-817 Association of Semaglutide and Tirzepatide Use on Bo · peer-reviewed · supports · weight 1.05 · 2025
Beyond Weight Loss: Skeletal Considerations in Obesity Treat · peer-reviewed · supports · weight 1.05 · 2026
Vertical sleeve gastrectomy and semaglutide have distinct ef · peer-reviewed · refutes · weight 1.3 · 2025
Semaglutide and Musculoskeletal Health: A Mendelian Randomiz · peer-reviewed · refutes · weight 1 · 2026

Evidence for · 4

Skeletal Effect of Semaglutide and Tirzepatide in Patients with Increased Risk of Fractures.

2026

A retrospective study found that semaglutide and tirzepatide use was associated with greater annualized total hip bone loss in patients without diabetes.

Get citation

Liu, Y., Walzer, D., Schmitz, S., Shukla, A. P., Ma, X., Chirko, D., Pipia, I., Sathi, S., Shukairy, U., Greenberg, M., Kashyap, S., & Stein, E. M. (2026). Skeletal Effect of Semaglutide and Tirzepatide in Patients with Increased Risk of Fractures.. doi.org. https://doi.org/10.1210/clinem/dgag052

Evidence against · 2

Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice

2025

A mouse study comparing bariatric surgery and semaglutide found that vertical sleeve gastrectomy caused significant bone loss, whereas 6 weeks of semaglutide treatment had no significant effects on the skeleton.

Get citation

Picoli, C. C., Tsibulnikov, S., Ho, M., Demambro, V. E., Feng, T., Eltahir, M., Le, P. T., Chlebek, C., Rosen, C., Ryzhov, S., & Li, Z. (2025). Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice. doi.org. https://doi.org/10.1152/ajpendo.00521.2024

See more details

More for · 3

Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites

2025

Preclinical research indicates that tirzepatide administration leads to reduced bone mass accrual and bone loss in animal models.

Get citation

Chen, N., Zhang, M., Shi, B., Luo, X., Huang, R., Luo, Z., He, J., Xue, S., Li, N., Ling, Z., Guo, H., Xu, R., & Liu, Y. (2025). Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites. doi.org. https://doi.org/10.1016/j.jot.2025.09.002

MON-817 Association of Semaglutide and Tirzepatide Use on Bone Density and Fracture Risk in Obese Patients with and without Diabetes

2025

A retrospective review of obese patients on semaglutide or tirzepatide observed significant declines in bone mineral density at the lumbar spine, femoral neck, and total hip.

Get citation

Liu, Y., Walzer, D., Schmitz, S., Shukla, A. P., Kashyap, S., & D’Angelo, D. (2025). MON-817 Association of Semaglutide and Tirzepatide Use on Bone Density and Fracture Risk in Obese Patients with and without Diabetes. doi.org. https://doi.org/10.1210/jendso/bvaf149.558

Beyond Weight Loss: Skeletal Considerations in Obesity Treatment.

2026

Reviews highlight that intentional weight loss via GLP-1RAs reduces bone mineral density, though direct preclinical signaling can sometimes show variable or protective effects.

Get citation

MJ, K. & YK, C. (2026). Beyond Weight Loss: Skeletal Considerations in Obesity Treatment.. doi.org. https://doi.org/10.3803/enm.2026.2986

More against · 1

Semaglutide and Musculoskeletal Health: A Mendelian Randomization Study Based on GLP-1 Receptor Expression.

2026

A Mendelian randomization study found no causal association between GLP-1 receptor expression and altered bone mineral density or osteoporosis, supporting a safe musculoskeletal profile.

Get citation

D, L., X, L., Z, L., H, Z., & H, L. (2026). Semaglutide and Musculoskeletal Health: A Mendelian Randomization Study Based on GLP-1 Receptor Expression.. doi.org. https://doi.org/10.2174/0118715303422692260617052555

Related receipts

Is it true that Ozempic causes loss of lean muscle mass during weight loss? SUPPORTED related question, same topic
Is it true that sharks have bones? REFUTED related question, same topic
Is it true that astronauts take pharmaceutical interventions to mitigate bone density loss? SUPPORTED related question, same topic
Is it true that people grow shorter as they age due to spinal disc compression and bone density loss? SUPPORTED related question, same topic
Is it true that all dinosaur bones are radioactive? REFUTED related question, same topic

What does the evidence say?

Receipt History

first checked06 Aug 2026

judged → CONTESTED · 4006 Aug 2026

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work